D. Western Therapeutics Institute, Inc.
Announcement on Monthly Exercise Status of the 13th Stock Acquisition Right (with Exercise Price Adjustment Clause)
Public disclosure of the August 2026 monthly exercise status for the 13th stock acquisition right (with exercise price adjustment clause). Exercised shares: 0 shares; exercise rate against total issued: 0.00%; unexercised rights: 8,338 units; issued shares: 57,559,412 shares (treasury shares: 11,387).
Key Figures
- Number of unexercised stock acquisition rights: 8,338 units
- Number of exercised stock acquisition rights: 0 units
- Total issued: 57,559,412 shares (including 11,387 treasury shares)
AI要約
Background and exercise status
This report summarizes the August 2026 monthly exercise status of the 13th stock acquisition right (with exercise price adjustment clause) issued on July 31, 2025. The number of shares delivered for the target month is 0 shares, the number of stock acquisition rights exercised is 0, with an exercise ratio of 0.000%. Unexercised stock acquisition rights for the target month total 8,338, and the compliance with exercise restrictions regarding the issued shares is 0%.
Share count and potential impact going forward
Total issued shares are 57,559,412, of which 11,387 are treasury shares. There were no actual exercises in the current month, and unexercised stock acquisition rights continue to exist. Indicators related to exercise restrictions are not applicable, and the company’s stock option policies remain unchanged. The potential market impact going forward is undetermined; timing and figures of any exercise will be disclosed in the next report.
D. Western Therapeutics Institute, Inc.
Company overview · Stock price · Financial data · All IR
